11th Annual Kraków HTA Symposium

Amendment to the Reimbursement Act: Implications for the healthcare system and health technology assessment

Speakers: 

• Mateusz Oczkowski, Department of Drug Policy, Ministry of Health 
• Daniel Rutkowski, Agency of Health Technology Assessment and Tarification, Poland* 
• Michał Byliniak, Association of Employers of Innovative Pharmaceutical Companies INFARMA 
• Krzysztof Kopeć, Polish Association of Pharmaceutical Industry Employers 
• Irena Rej, Izba Farmacja Polska 
• Paulina Kieszkowska/Bartłomiej Sasin, KRK Legal 
• Prof. Marcin Czech, Institute of Mother and Child 
• Waldemar Stylo, National Institute of Oncology 

JCA implementation in Central and Eastern Europe: Key findings and implications for medicines policy after six months

Speakers: 

• Anna Kowalczuk, Agency of Health Technology Assessment and Tarification, Poland* 
• Prof. Piotr Szymański, European Society of Cardiology 
• Katarina Beravs Bervar, Ministry of Health, Slovenia 
• Boryana Ivanova, National Council on Prices and Reimbursement, Bulgaria 
• Elvira Muller, Certara 
• Representative of HTA association, Hungary* 

The Role of Health Policy in Shaping Health Technology Assessment Outcomes: Perspectives from Poland and Neighboring Countries

Speakers: 

• Oresta Piniazhko, State Expert Center of the Ministry of Health of Ukraine 
• Elena Chitan, National Health Insurance Company, Moldova 
• Representative of Agency of Health Technology Assessment and Tarification, Poland* 
• Representative of National Institute for Value and Technologies in Health Care, Slovakia* 

Artificial Intelligence in the Synthesis of Evidence: Holy Grail or Trojan Horse?

Speakers: 

• Prof. Khalid Khan, University of Granada 
• Dr Juan Manuel Fernandez Luna, Univeristy of Granada 
• Prof. Javier Zamora, Univeristy of Madrid 
• Maciej Grys, Certara 
• Representative of Ministry of Health* 
• Representative of National Health Fund* 
• Representative of Agency of Health Technology Assessment* 

Medical Devices vs. Pharmacotherapy: Competition or Synergy in Modern Treatment 

• Arkadiusz Grądkowski, Polmed 
• Prof. Piotr Szymański, European Society of Cardiology 
• Prof. Maciej Banach, The Johns Hopkins University School of Medicine* 
• Michał Harańczyk, John Paul II Krakow Specialized Hospital* 
• Michał Chodorek, KRK Legal 

The impact of new diabetes drugs on the health care system, economy and society: Opportunities and challenges.

• Prof. Marcin Czech, Institute of Mother and Child 
• Katarzyna Głowińska, Obesity Treatment Foundation 
• Prof. Edward Franek, Hospital of the Ministry of Internal Affairs and Administration 
• Malwina Hołownia-Voloskova, Certara 

*Note on speakers: Subject to change based on availability.  

A registration fee of 3,000 PLN ($755 USD)** is required to attend the Krakow HTA Symposium. The fee covers

• 2 days attendance of all program sessions
• Coffee breaks
• Lunch breaks
• Dinner with experts
• Post-conference materials

**Note: Participation in the conference is free for government agencies.   

Upon receipt of registration, a conference organizer will contact you to process payment and provide additional details.

Hotel accommodations are not included as part of the event registration fee.